New for 2018, the PepTalk Innovations in Discovery & Development pipeline offers an in-depth examination of cutting-edge science and technology to support the discovery and development of novel and differentiated drug products. Full-length programs will consider strategies for delivering therapies across the blood-brain barrier and developing highly efficacious agents against CNS disorders, foundation level training in the rapidly emerging field of phenotypic screening and emerging display and sequencing technologies for antibody discovery.

January 8-9

Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier

January 9-10

Next-Generation Approaches to Antibody Screening and Discovery

January 11-12

Emerging Technologies for Antibody Discovery